Shipments of Duchenne Gene Therapy to Resume After FDA Review of Patient Death

(MedPage Today) — Drugmaker Sarepta Therapeutics said it would resume shipping its gene therapy for some patients, following a brief pause requested by regulators.
The FDA said it recommended lifting the hold for young patients with Duchenne…

Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/116714

Author :

Publish date : 2025-07-29 14:40:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Shipments of Duchenne Gene Therapy to Resume After FDA Review of Patient Death

‘Where Is Our Voice?’

Hiding in Not-So-Plain Sight: AI Spots Interval Breast Cancers Missed on Mammography

Related Posts

ECG Quirks Spotted After Gender-Affirming Hormone Therapy

Novel Drug May Help Speed Kids’ GI Recovery in Severe Post-COVID Syndrome

Medical Student Survey: How US Budget Bill Affects You

Is Psilocybin’s Depression Benefit Overestimated?

Want to Judge Data on FDA-Cleared AI Systems for Alzheimer’s? Good Luck With That

Can 3 Questions Flag Depression? PHQ-3 Tested

ECG Quirks Spotted After Gender-Affirming Hormone Therapy

Novel Drug May Help Speed Kids’ GI Recovery in Severe Post-COVID Syndrome

Medical Student Survey: How US Budget Bill Affects You

Is Psilocybin’s Depression Benefit Overestimated?

Want to Judge Data on FDA-Cleared AI Systems for Alzheimer’s? Good Luck With That

Can 3 Questions Flag Depression? PHQ-3 Tested

Trump Admin Is Launching a New Private Health Tracking System With Big Tech’s Help

Human trials point the way towards an mRNA vaccine against HIV

Categories

Archives